Cargando…

Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector

Industry 4.0 (I4.0) is helping production units to become smarter using cyber-physical systems and cognitive intelligence. The advanced diagnostics with I4.0 technologies (I4.0t) help in making the process highly flexible, resilient and autonomous. Still, the adoption of I4.0t especially in emerging...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Mahak, Sehrawat, Rajat, Giannakis, Mihalis, Dwivedi, Yogesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214346/
https://www.ncbi.nlm.nih.gov/pubmed/37361066
http://dx.doi.org/10.1007/s10479-023-05391-6
_version_ 1785047821750108160
author Sharma, Mahak
Sehrawat, Rajat
Giannakis, Mihalis
Dwivedi, Yogesh K.
author_facet Sharma, Mahak
Sehrawat, Rajat
Giannakis, Mihalis
Dwivedi, Yogesh K.
author_sort Sharma, Mahak
collection PubMed
description Industry 4.0 (I4.0) is helping production units to become smarter using cyber-physical systems and cognitive intelligence. The advanced diagnostics with I4.0 technologies (I4.0t) help in making the process highly flexible, resilient and autonomous. Still, the adoption of I4.0t especially in emerging economies like India is at a very slow pace. The present research has used an integrated approach i.e., Analytical Hierarchy Process-Combinative Distance-Based Assessment-Decision-Making Trial and Evaluation Laboratory to propose a barrier solution framework using data from pharmaceutical manufacturing sector. The findings reveal that “Costly venture” is found to be the most critical deterrent while “Customer awareness and satisfaction” is one of the potential solutions for I4.0t adoption. Further, lack of standardisation and fair benchmarking policies especially in the context of developing economies needs immediate attention. This article concludes by proposing a framework which will help to move from I4.0 towards Industry 4.0 + (I4.0+) which emphasises on role of collaboration between man and machine. And leads to sustainable supply chain management.
format Online
Article
Text
id pubmed-10214346
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-102143462023-05-30 Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector Sharma, Mahak Sehrawat, Rajat Giannakis, Mihalis Dwivedi, Yogesh K. Ann Oper Res Original Research Industry 4.0 (I4.0) is helping production units to become smarter using cyber-physical systems and cognitive intelligence. The advanced diagnostics with I4.0 technologies (I4.0t) help in making the process highly flexible, resilient and autonomous. Still, the adoption of I4.0t especially in emerging economies like India is at a very slow pace. The present research has used an integrated approach i.e., Analytical Hierarchy Process-Combinative Distance-Based Assessment-Decision-Making Trial and Evaluation Laboratory to propose a barrier solution framework using data from pharmaceutical manufacturing sector. The findings reveal that “Costly venture” is found to be the most critical deterrent while “Customer awareness and satisfaction” is one of the potential solutions for I4.0t adoption. Further, lack of standardisation and fair benchmarking policies especially in the context of developing economies needs immediate attention. This article concludes by proposing a framework which will help to move from I4.0 towards Industry 4.0 + (I4.0+) which emphasises on role of collaboration between man and machine. And leads to sustainable supply chain management. Springer US 2023-05-26 /pmc/articles/PMC10214346/ /pubmed/37361066 http://dx.doi.org/10.1007/s10479-023-05391-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Sharma, Mahak
Sehrawat, Rajat
Giannakis, Mihalis
Dwivedi, Yogesh K.
Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector
title Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector
title_full Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector
title_fullStr Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector
title_full_unstemmed Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector
title_short Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector
title_sort learnings from industry 4.0 for transitioning towards industry 4.0+: challenges and solutions for indian pharmaceutical sector
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214346/
https://www.ncbi.nlm.nih.gov/pubmed/37361066
http://dx.doi.org/10.1007/s10479-023-05391-6
work_keys_str_mv AT sharmamahak learningsfromindustry40fortransitioningtowardsindustry40challengesandsolutionsforindianpharmaceuticalsector
AT sehrawatrajat learningsfromindustry40fortransitioningtowardsindustry40challengesandsolutionsforindianpharmaceuticalsector
AT giannakismihalis learningsfromindustry40fortransitioningtowardsindustry40challengesandsolutionsforindianpharmaceuticalsector
AT dwivediyogeshk learningsfromindustry40fortransitioningtowardsindustry40challengesandsolutionsforindianpharmaceuticalsector